2025-08-12 |
13D/A
|
HRTX / Heron Therapeutics, Inc.
|
|
26,713,503 |
29,100,728 |
|
|
|
2025-07-09 |
13G/A
|
TLN / Talen Energy Corporation
|
|
6,123,500 |
4,505,302 |
|
|
|
2025-07-09 |
13G/A
|
QDEL / QuidelOrtho Corporation
|
|
5,550,000 |
4,637,738 |
|
|
|
2025-07-09 |
13G/A
|
OPK / OPKO Health, Inc.
|
|
48,706,640 |
47,791,243 |
|
|
|
2025-07-09 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
5,315,969 |
478,533 |
|
|
|
2025-07-09 |
13G/A
|
IART / Integra LifeSciences Holdings Corporation
|
|
4,643,672 |
7,353,934 |
|
|
|
2025-07-09 |
13G/A
|
ADPT / Adaptive Biotechnologies Corporation
|
|
14,400,000 |
6,256,847 |
|
|
|
2025-07-09 |
13G
|
TRVI / Trevi Therapeutics, Inc.
|
|
4,205,129 |
8,531,860 |
|
|
|
2025-07-09 |
13G/A
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
3,383,239 |
3,909,806 |
|
|
|
2025-07-09 |
13G
|
TAC / TransAlta Corporation
|
|
|
15,948,151 |
|
|
|
2025-05-14 |
13G/A
|
COLL / Collegium Pharmaceutical, Inc.
|
|
2,350,000 |
3,000,000 |
|
|
|
2025-05-14 |
13G
|
IART / Integra LifeSciences Holdings Corporation
|
|
|
4,643,672 |
|
|
|
2025-05-14 |
13G/A
|
GLNG / Golar LNG Limited
|
|
7,710,211 |
8,975,149 |
|
|
|
2025-05-14 |
13G/A
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
2,419,103 |
3,383,239 |
|
|
|
2025-05-14 |
13G/A
|
NFE / New Fortress Energy Inc.
|
|
15,000,000 |
24,338,675 |
|
|
|
2025-05-14 |
13G/A
|
GDRX / GoodRx Holdings, Inc.
|
|
5,804,628 |
0 |
|
|
|
2025-05-14 |
13G/A
|
DOLE / Dole plc
|
|
5,141,388 |
4,155,656 |
|
|
|
2025-02-13 |
13G/A
|
TLN / Talen Energy Corporation
|
|
11,368,614 |
6,123,500 |
|
|
|
2025-02-13 |
13G/A
|
TRVI / Trevi Therapeutics, Inc.
|
|
5,026,931 |
4,205,129 |
|
|
|
2025-02-13 |
13G/A
|
GLNG / Golar LNG Limited
|
|
6,506,757 |
7,710,211 |
|
|
|
2025-02-13 |
13G
|
GDRX / GoodRx Holdings, Inc.
|
|
4,680,028 |
5,804,628 |
|
|
|
2025-02-13 |
13G/A
|
SEG / Seaport Entertainment Group Inc.
|
|
276,942 |
573,408 |
|
|
|
2025-02-13 |
13G/A
|
QDEL / QuidelOrtho Corporation
|
|
4,200,000 |
5,550,000 |
|
|
|
2025-02-13 |
13G/A
|
CHRS / Coherus Oncology, Inc.
|
|
10,400,000 |
5,258,754 |
|
|
|
2025-02-13 |
13G
|
NFE / New Fortress Energy Inc.
|
|
|
15,000,000 |
|
|
|
2025-02-13 |
13G/A
|
MD / Pediatrix Medical Group, Inc.
|
|
8,275,000 |
3,148,440 |
|
|
|
2025-02-13 |
13G/A
|
SDGR / Schrödinger, Inc.
|
|
3,685,503 |
5,000,000 |
|
|
|
2025-02-13 |
13G
|
COLL / Collegium Pharmaceutical, Inc.
|
|
1,250,000 |
2,350,000 |
|
|
|
2024-11-13 |
13G
|
DOLE / Dole plc
|
|
|
5,141,388 |
|
|
|
2024-11-13 |
13G/A
|
COLL / Collegium Pharmaceutical, Inc.
|
|
2,758,253 |
1,250,000 |
|
|
|
2024-11-13 |
13G
|
CHRS / Coherus Oncology, Inc.
|
|
|
10,400,000 |
|
|
|
2024-11-13 |
13G/A
|
BGC / BGC Group, Inc.
|
|
20,000,000 |
16,972,580 |
|
|
|
2024-11-13 |
13G/A
|
SSYS / Stratasys Ltd.
|
|
4,250,000 |
6,191,000 |
|
|
|
2024-11-13 |
13G/A
|
ANIP / ANI Pharmaceuticals, Inc.
|
|
1,125,000 |
56,671 |
|
|
|
2024-11-13 |
13G
|
OPK / OPKO Health, Inc.
|
|
|
48,706,640 |
|
|
|
2024-11-13 |
13G
|
ADPT / Adaptive Biotechnologies Corporation
|
|
|
14,400,000 |
|
|
|
2024-11-13 |
13G/A
|
TRVI / Trevi Therapeutics, Inc.
|
|
5,684,420 |
5,026,931 |
|
|
|
2024-11-13 |
13G
|
MD / Pediatrix Medical Group, Inc.
|
|
|
8,275,000 |
|
|
|
2024-11-13 |
13G/A
|
GDRX / GoodRx Holdings, Inc.
|
|
5,872,806 |
4,680,028 |
|
|
|
2024-11-13 |
13G/A
|
HOWL / Werewolf Therapeutics, Inc.
|
|
1,935,357 |
1,333,893 |
|
|
|
2024-11-13 |
13G
|
ZYME / Zymeworks Inc.
|
|
|
3,917,331 |
|
|
|
2024-11-13 |
13G
|
QDEL / QuidelOrtho Corporation
|
|
|
4,200,000 |
|
|
|
2024-11-13 |
13G
|
RNW / ReNew Energy Global Plc
|
|
|
13,706,102 |
|
|
|
2024-11-13 |
13G
|
SDGR / Schrödinger, Inc.
|
|
|
3,685,503 |
|
|
|
2024-11-13 |
13G/A
|
STRO / Sutro Biopharma, Inc.
|
|
3,344,810 |
0 |
|
|
|
2024-11-13 |
13G
|
TLN / Talen Energy Corporation
|
|
|
11,368,614 |
|
|
|
2024-11-13 |
13G/A
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
2,907,501 |
2,419,103 |
|
|
|
2024-11-13 |
13G
|
SEG / Seaport Entertainment Group Inc.
|
|
|
276,942 |
|
|
|
2024-11-13 |
13G/A
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
6,644,530 |
10,966,672 |
|
|
|
2024-06-17 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
99,714,985 |
108,486,735 |
|
|
|
2024-06-11 |
13D/A
|
XPER / Xperi Inc.
|
|
4,043,744 |
4,143,744 |
|
|
|
2024-05-31 |
13D/A
|
XPER / Xperi Inc.
|
|
4,043,744 |
4,043,744 |
|
|
|
2024-05-31 |
13D/A
|
HRTX / Heron Therapeutics, Inc.
|
|
26,713,503 |
26,713,503 |
|
|
|
2024-04-16 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
99,704,885 |
99,714,985 |
|
|
|
2024-02-21 |
13D/A
|
XPER / Xperi Inc.
|
|
3,736,219 |
4,043,744 |
|
|
|
2024-02-14 |
13D/A
|
XPER / Xperi Inc.
|
|
3,301,219 |
3,736,219 |
|
|
|
2024-02-12 |
13G/A
|
BGC / BGC Group, Inc.
|
|
|
20,000,000 |
|
|
|
2024-02-12 |
13G/A
|
KOP / Koppers Holdings Inc.
|
|
1,133,840 |
1,007,341 |
|
|
|
2024-02-12 |
13G/A
|
HOWL / Werewolf Therapeutics, Inc.
|
|
1,835,387 |
1,935,357 |
|
|
|
2024-02-12 |
13G
|
SSYS / Stratasys Ltd.
|
|
|
4,250,000 |
|
|
|
2024-02-12 |
13G/A
|
PARR / Par Pacific Holdings, Inc.
|
|
3,049,000 |
1,199,749 |
|
|
|
2024-02-12 |
13G
|
SCPH / scPharmaceuticals Inc.
|
|
|
3,500,000 |
|
|
|
2024-02-12 |
13G
|
ANIP / ANI Pharmaceuticals, Inc.
|
|
|
1,125,000 |
|
|
|
2024-02-12 |
13G/A
|
COLL / Collegium Pharmaceutical, Inc.
|
|
3,333,628 |
2,758,253 |
|
|
|
2024-02-12 |
13G/A
|
LC / LendingClub Corporation
|
|
5,826,128 |
0 |
|
|
|
2024-02-12 |
13G
|
OFIX / Orthofix Medical Inc.
|
|
|
3,665,000 |
|
|
|
2024-02-12 |
13G/A
|
TRVI / Trevi Therapeutics, Inc.
|
|
5,684,420 |
5,684,420 |
|
|
|
2024-02-12 |
13G/A
|
PLYA / Playa Hotels & Resorts N.V.
|
|
11,876,728 |
4,431,161 |
|
|
|
2024-02-12 |
13G/A
|
TSAT / Telesat Corporation
|
|
1,410,000 |
959,764 |
|
|
|
2024-02-12 |
13G/A
|
MATV / Mativ Holdings, Inc.
|
|
3,020,000 |
4,000,000 |
|
|
|
2024-02-12 |
13G/A
|
STRO / Sutro Biopharma, Inc.
|
|
3,211,872 |
3,344,810 |
|
|
|
2024-02-12 |
13G/A
|
GLNG / Golar LNG Limited
|
|
6,352,756 |
6,506,757 |
|
|
|
2024-02-12 |
13G
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
2,907,501 |
|
|
|
2024-02-12 |
13G/A
|
DMRC / Digimarc Corporation
|
|
1,214,593 |
0 |
|
|
|
2024-02-12 |
13G/A
|
KPTI / Karyopharm Therapeutics Inc.
|
|
8,294,621 |
0 |
|
|
|
2024-02-12 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
6,828,065 |
5,315,969 |
|
|
|
2024-02-12 |
13G
|
ARQT / Arcutis Biotherapeutics, Inc.
|
|
|
6,644,530 |
|
|
|
2024-02-12 |
13G/A
|
CMRX / Chimerix, Inc.
|
|
4,779,020 |
0 |
|
|
|
2024-02-12 |
13G
|
GDRX / GoodRx Holdings, Inc.
|
|
|
5,872,806 |
|
|
|
2024-01-23 |
13D
|
XPER / Xperi Inc.
|
|
3,843,744 |
3,301,219 |
|
|
|
2023-11-20 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
97,326,555 |
99,704,885 |
|
|
|
2023-11-17 |
13D/A
|
TXMD / TherapeuticsMD, Inc.
|
|
2,069,716 |
2,946,908 |
|
|
|
2023-11-15 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
97,319,355 |
97,326,555 |
|
|
|
2023-11-13 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
95,561,160 |
97,319,355 |
|
|
|
2023-11-08 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
93,372,585 |
95,561,160 |
|
|
|
2023-11-06 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
92,291,205 |
93,372,585 |
|
|
|
2023-11-02 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
92,199,075 |
92,291,205 |
|
|
|
2023-10-31 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
90,030,600 |
92,199,075 |
|
|
|
2023-07-25 |
13D/A
|
HRTX / Heron Therapeutics, Inc.
|
|
11,750,000 |
26,713,503 |
|
|
|
2023-06-30 |
13D/A
|
TXMD / TherapeuticsMD, Inc.
|
|
1,721,953 |
2,069,716 |
|
|
|
2023-06-16 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
83,780,600 |
90,030,600 |
|
|
|
2023-05-02 |
13G
|
CMRX / Chimerix, Inc.
|
|
7,500,000 |
4,779,020 |
|
|
|
2023-02-22 |
13D/A
|
HRTX / Heron Therapeutics, Inc.
|
|
11,750,000 |
11,750,000 |
|
|
|
2023-02-10 |
13G
|
DMRC / Digimarc Corporation
|
|
|
1,214,593 |
|
|
|
2023-02-10 |
13G/A
|
EVER / EverQuote, Inc.
|
|
1,278,362 |
1,246,622 |
|
|
|
2023-02-10 |
13G
|
BGCP / BGC Partners Inc - Class A
|
|
|
18,250,000 |
|
|
|
2023-02-10 |
13G/A
|
GLNG / Golar LNG Limited
|
|
6,800,187 |
6,352,756 |
|
|
|
2023-02-10 |
13G/A
|
KOP / Koppers Holdings Inc.
|
|
1,109,120 |
1,133,840 |
|
|
|
2023-02-10 |
13G
|
STRO / Sutro Biopharma, Inc.
|
|
|
3,211,872 |
|
|
|
2023-02-10 |
13G
|
KPTI / Karyopharm Therapeutics Inc.
|
|
|
8,294,621 |
|
|
|
2023-02-10 |
13G
|
TRVI / Trevi Therapeutics, Inc.
|
|
|
5,684,420 |
|
|
|
2023-02-10 |
13G/A
|
PARR / Par Pacific Holdings, Inc.
|
|
3,700,000 |
3,049,000 |
|
|
|
2023-02-10 |
13G
|
OVID / Ovid Therapeutics Inc.
|
|
|
6,828,065 |
|
|
|
2023-02-10 |
13G
|
MATV / Mativ Holdings, Inc.
|
|
|
3,020,000 |
|
|
|
2023-02-10 |
13G/A
|
PLYA / Playa Hotels & Resorts N.V.
|
|
11,526,728 |
11,876,728 |
|
|
|
2023-02-10 |
13G/A
|
FREE / Whole Earth Brands, Inc.
|
|
3,100,000 |
998,363 |
|
|
|
2023-02-10 |
13G/A
|
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
|
|
17,722,340 |
18,000,000 |
|
|
|
2023-02-10 |
13G
|
HOWL / Werewolf Therapeutics, Inc.
|
|
|
1,835,387 |
|
|
|
2023-02-10 |
13G/A
|
VINC / Vincerx Pharma, Inc.
|
|
2,107,000 |
386,719 |
|
|
|
2023-02-10 |
13G/A
|
TSAT / Telesat Corporation
|
|
1,395,000 |
1,410,000 |
|
|
|
2023-02-10 |
13G/A
|
COLL / Collegium Pharmaceutical, Inc.
|
|
2,606,500 |
3,333,628 |
|
|
|
2023-02-10 |
13G/A
|
GSM / Ferroglobe PLC
|
|
13,648,711 |
3,232,762 |
|
|
|
2023-02-10 |
13G
|
SIOX / Sio Gene Therapies Inc.
|
|
|
7,000,000 |
|
|
|
2023-02-10 |
13G
|
XPER / Xperi Inc.
|
|
|
3,843,744 |
|
|
|
2023-02-10 |
13G
|
LC / LendingClub Corporation
|
|
|
5,826,128 |
|
|
|
2023-02-06 |
13D
|
HRTX / Heron Therapeutics, Inc.
|
|
|
11,750,000 |
|
|
|
2022-11-10 |
13D
|
CMRX / Chimerix, Inc.
|
|
4,800,000 |
7,500,000 |
|
|
|
2022-10-28 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
83,780,600 |
83,780,600 |
|
|
|
2022-09-23 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
83,780,600 |
83,780,600 |
|
|
|
2022-08-30 |
13D/A
|
TXMD / TherapeuticsMD, Inc.
|
|
1,721,953 |
1,721,953 |
|
|
|
2022-08-24 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
82,272,810 |
83,780,600 |
|
|
|
2022-08-08 |
13D
|
TXMD / TherapeuticsMD, Inc.
|
|
|
1,721,953 |
|
|
|
2022-06-16 |
13D
|
RDUS / Radius Recycling, Inc.
|
|
6,959,305 |
6,959,305 |
|
|
|
2022-06-14 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
76,792,625 |
82,272,810 |
|
|
|
2022-06-09 |
13D/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
75,000,000 |
76,792,625 |
|
|
|
2022-05-26 |
13D
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
74,572,235 |
75,000,000 |
|
|
|
2022-02-14 |
13G/A
|
MX / Magnachip Semiconductor Corporation
|
|
2,612,588 |
872,308 |
|
|
|
2022-02-14 |
13G
|
/ Core Scientific, Inc.
|
|
|
0 |
|
|
|
2022-02-14 |
13G
|
PLYA / Playa Hotels & Resorts N.V.
|
|
|
11,526,728 |
|
|
|
2022-02-14 |
13G
|
KOP / Koppers Holdings Inc.
|
|
|
1,109,120 |
|
|
|
2022-02-14 |
13G
|
GSM / Ferroglobe PLC
|
|
|
13,648,711 |
|
|
|
2022-02-14 |
13G
|
GLNG / Golar LNG Limited
|
|
|
6,800,187 |
|
|
|
2022-02-14 |
13G
|
EVER / EverQuote, Inc.
|
|
|
1,278,362 |
|
|
|
2022-02-14 |
13G
|
CMRX / Chimerix, Inc.
|
|
|
4,800,000 |
|
|
|
2022-02-14 |
13G
|
ATRS / Antares Pharma Inc
|
|
|
10,800,000 |
|
|
|
2022-02-14 |
13G
|
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
|
|
|
17,722,340 |
|
|
|
2022-02-14 |
13G/A
|
PARR / Par Pacific Holdings, Inc.
|
|
2,850,000 |
3,700,000 |
|
|
|
2022-02-14 |
13G/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
56,500,000 |
74,572,235 |
|
|
|
2022-02-14 |
13G/A
|
FREE / Whole Earth Brands, Inc.
|
|
2,600,000 |
3,100,000 |
|
|
|
2022-02-14 |
13G/A
|
COLL / Collegium Pharmaceutical, Inc.
|
|
1,926,283 |
2,606,500 |
|
|
|
2022-02-10 |
13G
|
VINC / Vincerx Pharma, Inc.
|
|
|
2,107,000 |
|
|
|
2022-01-21 |
13G
|
TSAT / Telesat Corporation
|
|
|
1,395,000 |
|
|
|
2022-01-03 |
13G
|
RDUS / Radius Recycling, Inc.
|
|
|
6,959,305 |
|
|
|
2021-12-02 |
13G
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
|
56,500,000 |
|
|
|
2021-06-07 |
13G
|
US16706W1027 / Chiasma Inc
|
|
|
7,250,000 |
|
|
|
2021-02-16 |
13G/A
|
MX / Magnachip Semiconductor Corporation
|
|
2,371,101 |
2,612,588 |
|
|
|
2021-02-16 |
13G/A
|
GPRE / Green Plains Inc.
|
|
2,335,000 |
1,056,330 |
|
|
|
2021-02-16 |
13G/A
|
UEPS / Lesaka Technologies Inc
|
|
2,977,922 |
2,132,622 |
|
|
|
2021-02-16 |
13G
|
FREE / Whole Earth Brands, Inc.
|
|
|
2,600,000 |
|
|
|
2021-02-16 |
13G
|
PARR / Par Pacific Holdings, Inc.
|
|
|
2,850,000 |
|
|
|
2021-02-16 |
13G
|
COLL / Collegium Pharmaceutical, Inc.
|
|
|
1,926,283 |
|
|
|
2020-02-14 |
13G/A
|
GPRE / Green Plains Inc.
|
|
2,486,820 |
2,335,000 |
|
|
|
2020-02-14 |
13G
|
STML / Stemline Therapeutics, Inc.
|
|
|
3,500,000 |
|
|
|
2020-02-14 |
13G
|
UEPS / Lesaka Technologies Inc
|
|
|
2,977,922 |
|
|
|
2020-02-14 |
13G/A
|
MX / Magnachip Semiconductor Corporation
|
|
3,000,000 |
2,371,101 |
|
|
|
2019-02-14 |
13G
|
GPRE / Green Plains Inc.
|
|
|
2,486,820 |
|
|
|
2019-02-14 |
13G/A
|
MX / Magnachip Semiconductor Corporation
|
|
2,250,500 |
3,000,000 |
|
|
|
2018-02-14 |
13G
|
MX / Magnachip Semiconductor Corporation
|
|
|
2,250,500 |
|
|
|